** The job cuts at the National Institutes of Health is "better than feared" signaling a "less bad" year compared to prior expectations for tools and diagnostics firms, brokerage Leerink Partners says
** The U.S. Department of Health and Human Services will cut about 10,000 full-time jobs and close half of its regional offices, and the NIH will see a reduction of 1,200 employees across its 27 institutes and centers
** "Anything less than feared is a positive for the NIH and US academic spending sentiment, which remains at an all-time low," Leerink analysts say
** The brokerage previously said it sees the worst sales impact for life sciences technology firms 10x Genomics TXG.O and Quanterix QTRX.O in Q1 on expected cost cuts at the NIH
** "The proposed 1,200 cuts is significantly below the 3,500-5,000 previously reported and should reduce the burden of working through the grant backlog created by a temporary pause in advisory council meetings"- Leerink
** However, the brokerage added that while the FY25 outlook is looking modestly improved, FY26 remains uncertain for life sciences technology firms
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.